[go: up one dir, main page]

IE790954L - Pharmaceutical formulations containing prostaglandin¹compounds - Google Patents

Pharmaceutical formulations containing prostaglandin¹compounds

Info

Publication number
IE790954L
IE790954L IE790954A IE95479A IE790954L IE 790954 L IE790954 L IE 790954L IE 790954 A IE790954 A IE 790954A IE 95479 A IE95479 A IE 95479A IE 790954 L IE790954 L IE 790954L
Authority
IE
Ireland
Prior art keywords
pharmaceutical formulations
formulations containing
prostacyclin
gb2021581a
dimethylprostacyclin
Prior art date
Application number
IE790954A
Other versions
IE48231B1 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IE790954L publication Critical patent/IE790954L/en
Publication of IE48231B1 publication Critical patent/IE48231B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Stabilised pharmaceutical formulations of prostacyclin, 15- methyl-prostacyclin or 16,16- dimethylprostacyclin are prepared by addition of a buffer comprising an amino acid (preferably glycine) as the principal buffering agent. [GB2021581A]
IE954/79A 1978-05-17 1979-08-08 Pharmaceutical formulations containing prostaglandin compounds IE48231B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17
GB7917158A GB2021581B (en) 1978-05-17 1979-05-17 Stabilisation of pgl derivatives

Publications (2)

Publication Number Publication Date
IE790954L true IE790954L (en) 1980-11-17
IE48231B1 IE48231B1 (en) 1984-11-14

Family

ID=26254508

Family Applications (1)

Application Number Title Priority Date Filing Date
IE954/79A IE48231B1 (en) 1978-05-17 1979-08-08 Pharmaceutical formulations containing prostaglandin compounds

Country Status (2)

Country Link
GB (1) GB2021581B (en)
IE (1) IE48231B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (en) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt PROSTAGLANDINE CONTAINING PHARMACEUTICAL PREPARATION
FR2740686B1 (en) * 1995-11-03 1998-01-16 Sanofi Sa STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION
SI1993557T1 (en) 2006-02-03 2016-01-29 Actelion Pharmaceuticals Ltd. Novel epoprostenol formulation and method of making thereof

Also Published As

Publication number Publication date
IE48231B1 (en) 1984-11-14
GB2021581B (en) 1982-10-20
GB2021581A (en) 1979-12-05

Similar Documents

Publication Publication Date Title
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
AU530380B2 (en) Amino acid derivatives as antihypertensives
IE790145L (en) 9-DEOXY-9a-METHYLENE ISOESTERS OF PGI(2)
AU596081B2 (en) Peptide usable as an intermediate for the production of a physiologically active peptide
EP0336760A3 (en) Bone-inducing protein
HUT52070A (en) Herbicide compositions containing pyrimidinyl-benzoic acid derivatives as active components, and process for producing the active components
IT8921118A0 (en) COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERIN AS THE ACTIVE INGREDIENT.
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
IE811650L (en) Stabilized thieno-pyridine compositions
AU525695B2 (en) Pharmaceutical formulations of prostacyclin
HK19095A (en) Pharmaceutical compositions containing ranitidine
EP0138616A3 (en) Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them
IE790954L (en) Pharmaceutical formulations containing prostaglandin¹compounds
AU578796B2 (en) Pesticidal compositions
AU1655388A (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
EP0226842A3 (en) Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them
IE811951L (en) Oxazaphosphorins
EP0063328A3 (en) Compositions containing secretin and method for preventing the adsorption of secretin
EP0315916A3 (en) A novel ether compound, a method for producing it, a composition containing it as an active ingredient and its use
EP0476156A4 (en) Solid oral preparation containing catechol compound
IE791818L (en) Endoparasiticidal paste
AU2403592A (en) 2-aza-2-desamino analogues of 5,8-dideazafolic acid
AU7927987A (en) Pharmaceutical peptide compositions, also containing poly-d-3-hydroxybutyric acid and calcium acetate/glycerol adduct
AU2130283A (en) Novel herbicides&n,n-dialkyl-2-(4:-substituted-1:napthoxy) propionamides
IE41017L (en) Thionophosphoric acid ester

Legal Events

Date Code Title Description
MK9A Patent expired